Nexien BioPharma, Inc. (NXEN)

0.0169 0.0000 (0.00%) At close: 09:30AM EDT

Nexien BioPharma, Inc.

4340 East Kentucky Avenue
Suite 206
Glendale, CO 80246
United States
303 495 7583
https://www.nexienbiopharma.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Richard S. Greenberg	Founder, CEO, Executive VP & Chairman	N/A	N/A	1949
Mr. Evan L. Wasoff CPA	Chief Financial Officer	N/A	N/A	1948
Mr. Robert I. Goldfarb J.D., Esq.	Chief Operating Officer	55k	N/A	1956

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Nexien BioPharma, Inc. focuses on the formulation, development, and commercialization of cannabinoid-based pharmaceuticals, drug delivery systems, and related technologies for diseases, disorders, and medical conditions. The company was formerly known as Intiva BioPharma Inc. and changed its name to Nexien BioPharma, Inc. in September 2018. Nexien BioPharma, Inc. is based in Glendale, Colorado.

Corporate governance

Nexien BioPharma, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.